sciences au lycée pierre termier Index du Forum
S’enregistrerRechercherFAQMembresGroupesConnexion
The 20182023 World Outlook For Overthecounter Pharmaceuti

 
Répondre au sujet    sciences au lycée pierre termier Index du Forum » sciences au lycée pierre termier » Chimie Sujet précédent
Sujet suivant
The 20182023 World Outlook For Overthecounter Pharmaceuti
Auteur Message
kanfio


Hors ligne

Inscrit le: 20 Mar 2016
Messages: 119
Localisation: Paris
Masculin

Message The 20182023 World Outlook For Overthecounter Pharmaceuti Répondre en citant

The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals
by Icon Group International



>>>DOWNLOAD BOOK The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals









The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals Icon Group International
The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals download book from sony xperia

Tags: francais ebook access online offline, read thepiratebay eReader sale book, kindle download free, free android audio selling djvu, book from motorola read, find audio pc bookstore book, book OneDrive, book Box, ebay spanish ebook book page, book BitTorrent free, book from htc online, read online pdf free, free ebook, free epub, download from SaberCatHost pdf, book DepositFiles, book for Windows Phone, ios read library pc thepiratebay, free macbook read, book online, wiki online full read shop, iphone value francais audio book, book samsung, You search pdf online pdf, mobile pdf, book for ibooks, book MediaFire, get free, download torrent ExtraTorrent, free download via uTorrent, book samsung, free docx, ebook free download, book ZippyShare, format txt pdf, download android



Life SciencesPharmaceuticalsOver-the-Counter Drugs The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals Lowest Prices Guaranteed Length Publisher Published Date SKU from $995 294 Pages Icon Group International, Inc1 INTRODUCTION1.1 OVERVIEW1.2 WHAT IS LATENT DEMAND AND THE P.I.E.?1.3 THE METHODOLOGY1.4 FREQUENTLY ASKED QUESTIONS (FAQ)2 SUMMARY OF FINDINGS2.1 THE WORLDWIDE MARKET POTENTIAL3 AFRICA3.1 EXECUTIVE SUMMARY3.2 ALGERIA3.3 ANGOLA3.4 BENIN3.5 BOTSWANA3.6 BURKINA FASO3.7 BURUNDI3.8 CAMEROON3.9 CAPE VERDE3.10 CENTRAL AFRICAN REPUBLIC3.11 CHAD3.12 COMOROS3.13 REPUBLIC OF CONGO3.14 COTE D'IVOIRE3.15 DJIBOUTI3.16 EGYPT3.17 EQUATORIAL GUINEA3.18 ETHIOPIA3.19 GABON3.20 THE GAMBIA3.21 GHANA3.22 GUINEA3.23 GUINEA-BISSAU3.24 KENYA3.25 LESOTHO3.26 LIBERIA3.27 LIBYA3.28 MADAGASCAR3.29 MALAWI3.30 MALI3.31 MAURITANIA3.32 MAURITIUS3.33 MOROCCO3.34 MOZAMBIQUE3.35 NAMIBIA3.36 NIGER3.37 NIGERIA3.38 RWANDA3.39 SAO TOME E PRINCIPE3.40 SENEGAL3.41 SIERRA LEONE3.42 SOMALIA3.43 SOUTH AFRICA3.44 SWAZILAND3.45 TANZANIA3.46 TOGO3.47 TUNISIA3.48 UGANDA3.49 CONGO (FORMERLY ZAIRE)3.50 ZAMBIA3.51 ZIMBABWE3.53 WESTERN SAHARA3.54 STConclusions8.1 The World OTC Pharma Market in 2014-20158.1.1 The Leading OTC Product Categories8.1.2 Leading OTC Pharma Brands, 20158.1.3 Leading OTC Manufacturers8.1.4 Leading National Markets: Emerging Market Represent a Large Proportion8.1.5 The Global OTC Market Growth Factors8.1.6 Potential OTC Switching, 2016-20268.1.7 Emerging OTC Markets8.2 Concluding RemarksAppendicesVisiongain's Bespoke Research ServiceSome Associated ReportsVisiongain Report Sales Order FormAbout VisiongainReport Evaluation FormList of TablesTable 1.1: The World OTC Pharmaceuticals Market Forecast by National Market: Revenue ($bn), AGR (%), and CAGR (%) 2014-2026Table 2.1 OTC Internal Analgesic Active Ingredients, 2016Table 2.2 OTC External Analgesic Active Ingredients, 2016Table 2.3 OTC Cough, Cold and Allergy Active Ingredients, 2016Table 2.4 OTC Antifungal Active Ingredients, 2016Table 2.5 OTC Indigestion and Heartburn Active Ingredients, 2016Table 2.6 OTC Anti-Diarrhoea Active Ingredients, 2016Table 2.7 OTC Laxative Active Ingredients, 2016Table 2.8 OTC Dry Eye Syndrome Active Ingredients, 2016Table 2.9 OTC Bacterial Conjunctivitis Active Ingredients, 2016Table 2.10 OTC Ocular Allergy Active Ingredients, 2016Table 2.11 OTC Smoking Cessation Aid Active Ingredients, 2016Table 3.1 World OTC Pharmaceutical Market Revenue by Product Category: Revenue ($bn) and Market Shares (%), 2015-2016Table 3.2 Top 10 OTC Pharmaceutical Products: Revenues ($m), 2015Table 3.3 Top 11 OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2014Table 3.4 Top 9 OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2015Table 3.5 World OTC Pharmaceuticals Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 3.6 The World OTC Pharmaceuticals Market Forecast by Product Category: Revenues ($bn), AGR (%), and CAGR (%), 2014-2026Table 3.7 The World OTC Pharmaceutical Market Forecast by Product Category: CAGR (%) for 2014-2020, 2020-2026 and 2014-2026Table 3.8 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2014, 2020 and 2026Table 3.9 The World OTC Pharmaceutical Market Forecast for the Cough, Cold and Allergy Market: Revenue ($bn), AGR (%), and CAGR (%), 2014-2026Table 3.10 The World OTC Pharmaceutical Market Forecast for the Analgesics Market: Revenue ($bn), AGR (%), and CAGR (%), 2014-2026Table 3.11 The Gastrointestinals OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026Table 3.12 The Dermatological OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026Table 3.13 The Eye Care OTC Pharma Market Forecast: Revenues ($bn), AGR (%), and CAGR (%), 2014-2026Table 3.14 The Smoking Cessation Aids OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026Table 3.15 The Other Products OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026Table 4.1 The World OTC Pharmaceutical Market: Revenues ($bn) and Market Shares (%) by Region, 2014Table 4.2 The World OTC Pharmaceutical Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2014-2026Table 4.3 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2020, 2020-2026 and 2014-2026Table 4.4 Market Shares (%) of the Leading Regional OTC Pharmaceutical Markets, 2014, 2020 and 2026Table 4.5 The US OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.6 Selected Leading Companies in the US OTC Pharma Market, 2015Table 4.7 The Japanese OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.8 Selected Leading Companies in the Japanese OTC Pharma Market, 2015Table 4.9 The EU5 Market: Revenue ($bn) and Market Share (%) by Region, 2014 and 2015Table 4.10 The EU5 OTC Pharma Market: Market Shares (%) by National Market, 2014, 2020, 2026Table 4.11 The EU5 OTC Pharma Market Forecast by Country: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.12 Selected Leading Companies in the EU5 OTC Pharma Market, 2015Table 4.13 The German OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.14 The UK OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.15 The French OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.16 The Italian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.17 The Spanish OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.18 The Chinese OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.19 Selected Leading Companies in the Chinese OTC Pharma Market, 2015Table 4.20 The Brazilian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.21 The Russian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.22 The Indian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.23 The Mexican OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table 4.24 The Rest of the World OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026Table5.1 Selected Leading OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2014Table 5.2 Selected OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2015Table5.3 GSK: Overview, 2015Table 5.4 GSK/Novartis OTC Brands, 2015Table 5.5 GSK Consumer Healthcare: OTC Sales Forecast ($Bb), AGR (%), and CAGR (%), 2015-2026Table 5.6 Panadol OTC Products, 2016Table 5.7 Novartis: Voltaren OTC Sales Forecast ($m), AGR (%), and CAGR (%), 2014-2026Table 5.8 Nicorette OTC Products, 2015Table 5.9 Bayer: Overview, 2016Table 5.10 Bayer OTC Brands, 2015Table 5.11 Bayer: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026Table 5.12 Bayer Aspirin: OTC Sales Forecast ($m), AGR (%), and CAGR (%), 2016-2026Table 5.13 Johnson & Johnson Overview, 2016Table 5.14 Johnson & Johnson OTC Brands, 2016Table 5.15 Johnson & Johnson: OTC Sales Forecast ($bn), AGR (%), CAGR (%), 2014-2026Table 5.16 Tylenol OTC Products, 2016Table 5.17 Nicorette OTC Products, 2016Table 5.18 Perrigo: Overview, 2016Table 5.19 Perrigo: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026Table 5.20 Pfizer: Overview, 2016Table 5.21 Pfizer OTC Brands, 2016Table 5.22 Pfizer: OTC Sales Forecast ($Bn), AGR (%), and CAGR (%), 2014-2026Table 5.23 Advil OTC Brands, 2016Table 5.24 Procter & Gamble: Overview, 2016Table 5.25 Reckitt Benckiser: Overview, 2016Table 5.26 Reckitt Benckiser: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026Table 5.27 Sanofi: Overview, 2016Table 5.28 Sanofi OTC Brands, 2016Table 5.29 Sanofi: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026Table 5.30 Boehringer Ingelheim: Overview, 2014Table 5.31 Boehringer Ingelheim OTC Brands, 2016Table 5.32 Boehringer Ingelheim: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026Table 6.1 US OTC Switches by Manufacturer, 2002-March 2015Table 6.2 Potential Cough, Cold and Allergy OTC Switches By Active Ingredient, 2015-2016Table 6.3 Potential Analgesics OTC Switches by Active Ingredient, 2016-2026Table 6.4 Potential Gastrointestinals OTC Switches By Active Ingredient, 2016-2026Table 6.5 Potential Dermatologicals OTC Switches By Active Ingredient, 2016-2025Table 7.1 SWOT Analysis of the OTC Pharmaceutical Market, 2016List of FiguresFigure 1.1 OTC Pharmaceuticals: Overview of SubmarketsFigure 2.1 The OTC Pharmaceutical Supply Chain, 2016Figure 3.1 World OTC Pharmaceutical Market Share(%) of the World Pharmaceutical Market, 2015Figure 3.2 World OTC Pharmaceutical Market by Product Category: Market Shares(%), 2015Figure 3.3 The World OTC Pharmaceuticals Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 3.4 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2014-2020Figure 3.5 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2020-2026Figure 3.6 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2014-2026Figure 3.7 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2020Figure 3.8 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2026Figure 3.9 Comparison of the World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2014 and 2026Figure 3.10 The OTC Pharmaceutical Market Forecast for the Cough, Cold and Allergy Market: Revenues ($bn) and AGR (%) 2014-2026Figure 3.11 The World OTC Pharmaceutical Market Forecast for the Analgesics Market: Revenues ($bn) and AGR (%) 2014-2026Figure 3.12 The Gastrointestinals OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 3.13 The Dermatological OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 3.14 The Eye Care OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 3.15 The Smoking Cessation Aids OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 3.16 The Other Products OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.1 The World OTC Pharmaceutical Market: Revenues ($bn) by Region,2014Figure 4.2 The World OTC Pharmaceutical Market: Market Shares (%) by Region,2014Figure 4.3 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2020Figure 4.4 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2020-2026Figure 4.5 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2026Figure 4.6 The World OTC Pharmaceutical Market: Market Shares (%) by Region, 2020Figure 4.7 The World OTC Pharmaceutical Market: Market Shares (%) by Region, 2026Figure 4.8 The US OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.9 The Japanese OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.10 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2014Figure 4.11 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2020Figure 4.12 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2026Figure 4.13 The EU5 OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.14 The German OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.15 The UK OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.16 The French OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.17 The Italian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.18 The Spanish OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.19 The Chinese OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.20 The Brazilian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.21 The Russian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.22 The Indian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.23 The Mexican OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 4.24 The Rest of the World OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026Figure 5.1 Selected Leading OTC Pharmaceutical Manufacturers by Market Share (%), 2014Figure 5.2 Selected OTC Pharmaceutical Manufacturers by Market Share (%), 2015Figure 5.3 GSK Consumer Healthcare: OTC Sales Forecast ($m), and AGR (%), 2015-2026Figure 5.4 Novartis: Voltaren OTC Sales Forecast ($m), and AGR (%), 2014-2026Figure 5.5 Bayer: OTC Sales Forecast ($bn), and AGR (%), 2014-2026Figure 5.6 Bayer Aspirin: OTC Sales Forecast ($m), and AGR (%), 2014-2026Figure 5.7 Johnson & Johnson: OTC Sales Forecast ($bn), AGR (%),2014-2026Figure 5.8 Perrigo: OTC Sales Forecast ($bn), and AGR (%), 2014-2026Figure 5.9 Pfizer: OTC Sales Forecast ($bn), AGR (%), 2014-2026Figure 5.10 Reckitt Benckiser: OTC Sales Forecast ($Bn), and AGR (%), 2014-2026Figure 5.11 Sanofi: OTC Sales Forecast ($bn), and AGR (%), 2014-2026Figure 5.12 Boehringer Ingelheim: OTC Sales Forecast ($bn), AGR (%), 2014-2026Figure 6.1 Number of FDA-Approved OTC Switches, By Year, 1976-2014Figure 6.2 Number of FDA-Approved OTC Switches, By 5-Year Periods, 1976-2014Figure 7.1 Porter's Five Analysis of the OTC Pharmaceutical Market , 2016Figure 8.1 The World OTC Pharmaceutical Market: Market Share (%) by Region, 2014Figure 8.2 The World OTC Pharmaceutical Market Forecast: Revenue ($bn) and AGR (%), 2014-2026 Companies ListedAbbott Medical OpticsAch Laboratrios FarmacuticosActavisAdams Respiratory TherapeuticsAkornAlconAllerganAlliance BootsAlmirallAmerisource BergenANVISAApotexArena PharmaceuticalsAspen PharmacareAstellas PharmaAstraZenecaAurobindoB.FYou will find discussions, including qualitative analyses: - Highly fragmented and competitive market with significant variations in different geographic regions - Changing political and regulatory landscape changing the prospects of future successful OTC switches - Significant company M&A activity changing the competitive landscape of the whole marketYou will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.How The World OTC Pharmaceuticals Market Forecast 2016-2026 report helps youIn summary, our 247-page report gives you the following knowledge: - Revenue forecasts to 2026 for the OTC pharma market discover the industrys prospects, finding promising places for investments and revenues - Revenue forecasts to 2026 for each major submarket discover prospects for leading over-the-counter medicine products in the following areas: cough, cold and allergy, analgesics, gastrointestinal, dermatological, eye care, and smoking cessation aidsFixed-Parameter Linear EstimationVINCENT AND THE GRENADINES7.23 TRINIDAD AND TOBAGO7.24 THE UNITED STATES7.25 GREENLAND7.26 MONTSERRAT7.27 ST PIERRE AND MIQUELON7.28 TURKS AND CAICOS ISLANDS7.29 THE U.S1.3 The Methodology

He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research Jessica P Huffman Research Associate at American Transportation Research Institute Excellent customer serviceVIRGIN ISLANDS7.30 CURACAO7.31 SINT MAARTEN8 OCEANIA8.1 EXECUTIVE SUMMARY8.2 AMERICAN SAMOA8.3 AUSTRALIA8.4 FIJI8.5 FRENCH POLYNESIA8.6 GUAM8.7 KIRIBATI8.8 NAURU8.9 NEW CALEDONIA8.10 NEW ZEALAND8.11 SOLOMON ISLANDS8.12 TONGA8.13 TUVALU8.14 VANUATU8.15 WESTERN SAMOA8.16 COOK ISLANDS8.17 NIUE8.18 WALLIS AND FUTUNA8.19 MARSHALL ISLANDS8.20 MICRONESIA FEDERATION8.21 CHRISTMAS ISLAND8.23 NORFOLK ISLAND8.24 THE NORTHERN MARIANA ISLAND8.26 TOKELAU8.27 PALAU9 THE MIDDLE EAST9.1 EXECUTIVE SUMMARY9.2 AFGHANISTAN9.3 BAHRAIN9.4 IRAN9.5 IRAQ9.6 ISRAEL9.7 JORDAN9.8 KUWAIT9.9 LEBANON9.10 OMAN9.11 PAKISTAN9.12 QATAR9.13 SAUDI ARABIA9.14 SYRIAN ARAB REPUBLIC9.15 TURKEY9.16 THE UNITED ARAB EMIRATES9.17 ARMENIA9.18 AZERBAIJAN9.19 KYRGYZSTAN9.20 TAJIKISTAN9.21 TURKMENISTAN9.22 UZBEKISTAN9.23 YEMEN9.24 PALESTINE10 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS10.1 DISCLAIMERS & SAFE HARBOR10.2 ICON GROUP INTERNATIONAL, INCis divided across the world's regional and national marketsA relatively harsh winter and extended flu season increased demand for cough, cold and allergy (hay fever) remedies in winter 2015-2016But even frequent troubled sleep is commonplace, dollars), the percent share the country is of the region, and of the globeFilling In Missing Values

Executive Director at PwC Advisory The customer service was fast, responsive, and 100% professional in all my dealings (.) If we have more research needs, I'll certainly prioritize working with ReportLinker! Scott Griffith Vice President Marketing at Maurice Sporting Goods The research specialist provided prompt, helpful instructions for accessing ReportLinker's productForecasts to 2020 illustrate how the market is set to change.Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations- Detailed profiles or revenue forecasts to 2026 for the leading drugs in the over-the-counter medicine market discover prospects for leading over-the-counter brands: Voltaren, and Bayer Aspirin and profiles for Panadol, Alli, Flonase Allergy Relief, Claritin, Tylenol, Rhinocort Allergy, Nicorette, Nexium, Advil, Prilosec OTC, Mucinex, Nasacort, Allegra, Clarinex - Revenue forecasts to 2026 for twelve leading national market and one leading regional markets US, EU5, China, Japan, India, Russia, Brazil, and MexicoUSER AGREEMENT PROVISIONS Skip to top MORE PUBLICATIONS Global Over-the-Counter Pharmaceuticals Market Research Report 2017 US$ 2,850.00 Feb, 2017 165 pages Global Gastrointestinal Over the Counter (OTC) Drugs Market Research Report 2017 US$ 2,850.00 Feb, 2017 165 pages ACP Fourth Bridge Over The Panama Canal Panama Project Profile US$ 75.00 Mar, 2017 7 pages The United Kingdom: laboratory and pharmaceutical glassware market US$ 1,999.00 Aug, 2016 Global and Chinese OTT (Over-The-Top) TV Without Borders Industry, 2017 Market Research Report US$ 3,000.00 May, 2017 150 pages Ask Your Question The 2018-2023 World Outlook for Over-the-counter Pharmaceuticals Company name*: Contact person*: Phone/fax*: Email*: Request invoice Your enquiry: Please click on a Check Box below to confirm you are not a robot: Market Reports All Categories Agriculture Agribusiness Agricultural Products Animal Husbandry Fisheries Fertilizers Gardening & Forestry Construction Building Materials Building Products Company Reports Commercial Construction Engineering & Construction Services Company Report Industrial Construction Infrastructure Residential Construction Defence & Security Aerospace & Defense Company Reports Energy Alternative Energy Batteries & Accumulators Electric Power Energy Company Reports Nuclear Power Smart Grid Thermal Power Machinery & Equipment Equipment Machinery Metallurgy Alkali & Alkaline Earth Metals Ferrous Metallurgy Metal Alloys Metal Products Metals & Mining Company Reports Non-Ferrous Metallurgy Precious Metals Rare-Earth Metals Uranous Metals (Actinoid) Mineral Raw Materials Building Raw Materials & Fillers Conglomerates Company Reports Fossil Fuel Nonmetallic Minerals Metalloids Ores Precious & Semi-Precious Stones Packaging Industry Packaging & Containers Company Reports Publishing Industry Pulp & Paper Paper & Forest Products Company Reports Vehicle Aerospace & Aviation Electric Vehicles Motor Vehicles Railway Sea Transport Other Industries April 2017 $ 995 The 2018-2023 World Outlook For Over-the-c Latest reports & slideshows with insights from top research analysts 60 Million searchable statistics with tables, figures & datasets More than 25,000 trusted sources €800 - 1 User License €1600 - Site License €2400 - Corporate License Single User License provides access to the report by one individualAlthough only about 2 million cases of sleep apnea have been diagnosed in the U.S., the actual number of individuals suffering from the condition is estimated at between 15 to 30 million, with different groups using various methodologies to arrive at different estimatesPhone: 800.298.5699 (US) or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 3:00am - 6:30pm EST Fridays: 3:00am - 5:30pm EST Email: customerservicemarketresearch.com Copyright 1999-2017, All Rights Reserved, MarketResearch.com Marketresearch.com About Us Privacy Policy Terms and Conditions Return Policy Research index Help Help FAQs Customer Service Contact Us 7/9/2017 - 133 .Mariana Mendoza Global Platform Senior Manager at Whirlpool Corporation Thanks! I like what you've provided and will certainly come back if I need to do further research works

OTC Approval6.5 Analgesics: OTC Switch Limitations6.5.1 Triptans: The U.SRead More The 2018-2023 World Outlook for Herbal Sleep Aids Feb 07, 2017 USD 995 .or potential industry earnings (P.I.E.), for the country in question (in millions of U.SRead More Global Polysomnography Market Research Report 2017 Apr 15, 2017 USD 2,850 .the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China)Hasegawa Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 33 Table Kerry Basic Information, Manufacturing Base and Competitors 34 Table Kerry Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 35 Table McCormick Basic Information, Manufacturing Base and Competitors 35 Table McCormick Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 36 Table Synergy Flavor Basic Information, Manufacturing Base and Competitors 36 Table Synergy Flavor Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 38 Table Prova Basic Information, Manufacturing Base and Competitors 38 Table Prova Flavor and Fragrance 39 Table Prova Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 39 Table Huabao Basic Information, Manufacturing Base and Competitors 40 Figure Huabao Flavor and Fragrance Picture 41 Table Huabao Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 41 Table Yingyang Basic Information, Manufacturing Base and Competitors 42 Figure Product Introduction 43 Table Yingyang Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 43 Table Zhonghua Basic Information, Manufacturing Base and Competitors 43 Figure Zhonghua Flavor and Fragrance Picture 45 Table Zhonghua Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 45 Table Shanghai Apple Basic Information, Manufacturing Base and Competitors 46 Figure Shanghai Apple Flavor and Fragrance Picture 47 Table Shanghai Apple Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 47 Table Wanxiang International Basic Information, Manufacturing Base and Competitors 48 Figure Wanxiang International Flavor and Fragrance Picture 49 Table Wanxiang International Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 49 Table Boton Basic Information, Manufacturing Base and Competitors 50 Figure Boton Flavor and Fragrance Picture 51 Table Boton Flavor and Fragrance Sales (MT), Price (USD/MT), Revenue (Million USD), Gross Margin and Market Share (2016-2017) 51 Table Global Flavor and Fragrance Sales by Manufacturer (2016-2017) (MT) 53 Figure Global Flavor and Fragrance Sales Market Share by Manufacturer in 2016 54 Figure Global Flavor and Fragrance Sales Market Share by Manufacturer in 2017 55 Table Global Flavor and Fragrance Revenue by Manufacturer (2016-2017) (Million USD) 56 Figure Global Flavor and Fragrance Revenue Market Share by Manufacturer in 2016 57 Figure Global Flavor and Fragrance Revenue Market Share by Manufacturer in 2017 58 Figure 2016 Top 3 Flavor and Fragrance Manufacturer Revenue Market Share 59 Figure 2016 Top 6 Flavor and Fragrance Manufacturer Revenue Market Share 60 Figure Top 3 Flavor and Fragrance Manufacturer Revenue Market Share 2012-2017 61 Figure Top 6 Flavor and Fragrance Manufacturer Revenue Market Share 2012-2017 61 Figure Global Flavor and Fragrance Sales and Growth (2012-2017) 62 Figure Global Flavor and Fragrance Revenue and Growth (2012-2017) 63 Table Global Flavor and Fragrance Sales by Regions (2012-2017) 63 Table Global Flavor and Fragrance Sales Market Share by Regions (2012-2017) 63 Table Global Flavor and Fragrance Revenue by Regions (2012-2017) 64 Figure Global Flavor and Fragrance Revenue Market Share by Regions in 2012 64 Figure Global Flavor and Fragrance Revenue Market Share by Regions in 2016 65 Figure USA Flavor and Fragrance Sales and Growth (2012-2017) 65 Figure Europe Flavor and Fragrance Sales and Growth (2012-2017) 66 Figure Asia-Pacific Flavor and Fragrance Sales and Growth (2012-2017) 67 Figure South America Flavor and Fragrance Sales and Growth (2012-2017) 68 Figure USA Flavor and Fragrance Revenue and Growth (2012-2017) 69 Figure USA Flavor and Fragrance Sales and Growth (2012-2017) 69 Figure Europe Flavor and Fragrance Revenue and Growth (2012-2017) 70 Table Europe Flavor and Fragrance Sales by Countries (2012-2017) (MT) 70 Table Europe Flavor and Fragrance Sales Market Share by Countries (2012-2017) 71 Table Europe Flavor and Fragrance Revenue by Countries (2012-2017) (Million USD) 71 Figure Europe Flavor and Fragrance Revenue Market Share by Countries in 2012 72 Figure Europe Flavor and Fragrance Revenue Market Share by Countries in 2016 72 Figure Germany Flavor and Fragrance Sales and Growth (2012-2017) 73 Figure UK Flavor and Fragrance Sales and Growth (2012-2017) 74 Figure France Flavor and Fragrance Sales and Growth (2012-2017) 75 Figure Switzerland Flavor and Fragrance Sales and Growth (2012-2017) 76 Figure Italy Flavor and Fragrance Sales and Growth (2012-2017) 77 Figure Asia-Pacific Flavor and Fragrance Revenue and Growth (2012-2017) 78 Table Asia-Pacific Flavor and Fragrance Sales by Countries (2012-2017) (MT) 78 Table Asia-Pacific Flavor and Fragrance Sales Market Share by Countries (2012-2017) 79 Figure Asia-Pacific Flavor and Fragrance Sales Market Share by Countries (2012-2017) 79 Table Asia-Pacific Flavor and Fragrance Revenue by Countries (2012-2017) (Million USD) 80 Figure Asia-Pacific Flavor and Fragrance Revenue Market Share by Countries (2012-2017) 80 Figure China Flavor and Fragrance Sales and Growth (2012-2017) 81 Figure Japan Flavor and Fragrance Sales and Growth (2012-2017) 82 Figure Korea Flavor and Fragrance Sales and Growth (2012-2017) 83 Figure India Flavor and Fragrance Sales and Growth (2012-2017) 84 Figure South America Flavor and Fragrance Revenue and Growth (2012-2017) 85 Table South America Flavor and Fragrance Sales by Countries (2012-2017) (MT) 85 Table South America Flavor and Fragrance Sales Market Share by Countries (2012-2017) 86 Figure South America Flavor and Fragrance Sales Market Share by Countries in 2012-2017 86 Table South America Flavor and Fragrance Revenue by Countries (2012-2017) (Million USD) 87 Table South America Flavor and Fragrance Revenue Market Share by Countries (2012-2017) 87 Figure South America Flavor and Fragrance Revenue Market Share by Countries in 2012-2017 88 Figure Brazil Flavor and Fragrance Sales and Growth (2012-2017) 89 Figure Argentina Flavor and Fragrance Sales and Growth (2012-2017) 90 Figure Columbia Flavor and Fragrance Sales and Growth (2012-2017) 91 Table Flavor and Fragrance Sales Revenue (Million USD) by Company in USA 2012-2017 92 Table Flavor and Fragrance Sales Share by Company in USA 2012-2017 92 Figure Flavor and Fragrance Sales Share by Company in USA 2012-2017 93 Table Flavor and Fragrance Sales Revenue (Million USD) by Company in Europe 2012-2017 93 Table Flavor and Fragrance Sales Share by Company in Europe2012-2017 94 Figure Flavor and Fragrance Sales Share by Company in Europe2012-2016 95 Table Flavor and Fragrance Sales Revenue (Million USD) by Company in Asia-Pacific 2012-2017 95 Table Flavor and Fragrance Sales Share by Company in Asia-Pacific 2012-2017 96 Figure Flavor and Fragrance Sales Share by Company in Asia-Pacific 2012-2017 97 Table Flavor and Fragrance Sales Revenue (Million USD) by Company in South America 2012-2017 97 Table Flavor and Fragrance Sales Share by Company in South America2012-2017 97 Figure Flavor and Fragrance Sales Share by Company in South America2012-2017 98 Table Global Flavor and Fragrance Sales by Type (2012-2017) (MT) 99 Table Global Flavor and Fragrance Sales Share by Type (2012-2017) 99 Table Global Flavor and Fragrance Revenue by Type (2012-2017) (Million USD) 99 Table Global Flavor and Fragrance Revenue Share by Type (2012-2017) 100 Figure Global Flavor Sales Growth (2012-2017) 100 Figure Global Flavor Price (2012-2017) (USD/MT) 101 Figure Global Fragrance Sales Growth (2012-2017) 102 Figure Global Fragrance Price (2012-2017) (USD/MT) 103 Table Global Flavor and Fragrance Sales by Application (2012-2017) (MT) 104 Table Global Flavor and Fragrance Sales Share by Application (2012-2017) 104 Figure Global Food and Beverages Sales Growth (2012-2017) (MT) 105 Figure Global Daily Chemicals Sales Growth (2012-2017) 105 Figure Global Tobacco Industry Sales Growth (2012-2017) (MT) 106 Figure Global Flavor and Fragrance Sales and Growth Rate (2018-2023) 107 Figure Global Flavor and Fragrance Revenue and Growth Rate (2018-2023) 108 Table Global Flavor and Fragrance Sales Forecast by Regions (2018-2023) (MT) 108 Table Global Flavor and Fragrance Market Share Forecast by Regions (2018-2023) 108 Figure USA Sales Flavor and Fragrance Market Forecast (2018-2023) 109 Figure Europe Sales Flavor and Fragrance Market Forecast (2018-2023) 110 Figure Asia-Pacific Sales Flavor and Fragrance Market Forecast (2018-2023) 111 Figure South America Sales Flavor and Fragrance Market Forecast (2018-2023) 112 Table Global Flavor and Fragrance Sales Forecast by Type (2018-2023) (MT) 112 Table Global Flavor and Fragrance Market Share Forecast by Type (2018-2023) 113 Table Global Flavor and Fragrance Sales Forecast by Application (2018-2023) (MT) 113 Table Global Flavor and Fragrance Market Share Forecast by Application (2018-2023) 113 Figure Marketing Channels of Flavor and Fragrance 114 Table Distributors/Traders/ Dealers List 117 REQUEST COMPANIES MENTIONED IN THIS REPORT Country Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Guernsey Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Honduras Hong Kong Hungary Iceland India Isle of Man Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Ivory Coast Jersey Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea Democratic People Korea Kosovo Kuwait Kyrgyzstan Lao Peoples Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia South Sandwich Islands Spain Sri Lanka StFebruary, 2017 ICN15241167 Lowest Prices Guaranteed Price from $995 Length 294 Pages Publisher Icon Group International, IncHelena StUnique Device Identification (UDI) initiative by the FDA, Growing adoptio.Continue reading Top 10 Medical Device Technologies Market By Type (IVD, Cardiology, Diagnostic Imaging, Orthopedics, Ophthalmology, Endoscopy, Diabetes Care, Wound Management, Kidney/Dialysis and Anesthesia & Respiratory Care Devices) Analysis & Forecast The Global Top 10 Medical Device Technologies Market is anticipated to extent USD 428,970.7 million by 2020, growing at a CAGR of 5.5% during the forecast period (2015 to 2020)Sleep apnea, a potentially serious disorder, is usually the result of breathing irregularities and can result in a range of consequences including daytime sleepiness and irritability to increased risk of accidents and hypertension 5d8a9798ff



Food For Thought - 2nd Edition: 21 ways to gaurantee success. Junior GoudeBirthday Wishes for Eve: Personalized Book with Birthday Wishes for Kids (Birthday Poems for Kids, Personalized Books, Birthday Gifts, Gifts for Kids)The 2018-2023 World Outlook for Natural Gas Refueling Icon Group InternationalWHAT IS THE FATHER STEPHEN’S 56TH MEDICAL DISEASE LINKED TO THE UNIVERSAL LAW IN THE HOLY BIBLESouth Africa Social Security System, Policies, Laws and Regulations Handbook: Strategic Information and Basic Laws (World Business and Investment Library) International Business PublicationsThe Book of Perfectly Perilous Math: 24 Death-Defying Challenges for Young Mathematicians (Irresponsible Science)Trends in Energy Use in Industrial Societies: An OverviewThe Ecclesiology of Stanley Hauerwas: A Christian Theology of Liberation (Routledge New Critical Thinking in Religion, Theology and Biblical Studies) John B. ThomsonEn el agua (On Water) (Science Readers: Content and Literacy) (Spanish Edition)Faith Builders Joan Pearce



Dim 9 Juil - 15:05 (2017)
Publicité






Message Publicité
PublicitéSupprimer les publicités ?

Dim 9 Juil - 15:05 (2017)
Montrer les messages depuis:    
Répondre au sujet    sciences au lycée pierre termier Index du Forum » sciences au lycée pierre termier » Chimie Toutes les heures sont au format GMT + 2 Heures
Page 1 sur 1

 
Sauter vers: 

Index | Panneau d’administration | creer un forum | Forum gratuit d’entraide | Annuaire des forums gratuits | Signaler une violation | Conditions générales d'utilisation
Powered by phpBB © 2001, 2005 phpBB Group
Design by Freestyle XL / Music Lyrics.Traduction par : phpBB-fr.com